Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms
Laura F. Mendez Luque, Amanda Blackmon, Gajalakshmi Ramanathan, et al.
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 3, pp. 145-153
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

The Systemic Inflammation Index: A New Candidate Minor Criterion in the Diagnosis of Polycythemia Vera
Emine Gültürk, Korhan Kapucu
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease
Joelle Hallak, Ali Abbasi, Roger A. Goldberg, et al.
JAMA Ophthalmology (2024) Vol. 142, Iss. 8, pp. 750-750
Open Access | Times Cited: 1
Neutrophil‐to‐lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: A new promising predictor of thrombotic events
A. Ripamonti, Fabrizio Cavalca, Laura Montelisciani, et al.
Cancer (2024)
Open Access | Times Cited: 1
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
Peter Müller, Conny K. Baldauf, Tobias R. Haage, et al.
Blood Advances (2021) Vol. 5, Iss. 23, pp. 5349-5359
Open Access | Times Cited: 9
Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway
Charlotte Liisborg
Acta Ophthalmologica (2022) Vol. 100, Iss. S271, pp. 3-35
Open Access | Times Cited: 6
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
Nathan P. Horvat, Enas Abdallah, Zhuoer Xie, et al.
Annals of Hematology (2023) Vol. 103, Iss. 1, pp. 117-123
Closed Access | Times Cited: 3
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Snjezana Janjetovic, Lennart Beckmann, Katharina Holstein, et al.
Thrombosis Research (2020) Vol. 198, pp. 55-61
Closed Access | Times Cited: 8
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5495-5495
Open Access | Times Cited: 4
Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective
Yiming Feng, Yue Zhang, Jialan Shi
Platelets (2022) Vol. 33, Iss. 7, pp. 955-963
Closed Access | Times Cited: 3
Metformin for MPN: teaching an old drug new tricks
Michelle Lee, Gabriela S. Hobbs
Blood Advances (2024) Vol. 8, Iss. 16, pp. 4476-4477
Closed Access
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms
Mirjana Cvetković, Isidora Arsenović, Mihailo Smiljanić, et al.
Annals of Hematology (2024)
Closed Access
CXCL10 Induces Lytic Reactivation of EBV through <i>EXTL</i>1
Bei-Ning Ding, Yi‐Lin Wu, You-Yu Zhang, et al.
Advances in Bioscience and Biotechnology (2024) Vol. 15, Iss. 10, pp. 621-635
Open Access
Ph-Negative Chronic Myeloproliferative Neoplasms
Monia Marchetti
Elsevier eBooks (2024), pp. 120-143
Closed Access
Myeloproliferative Neoplasms Transcriptome Reveals Pro-Inflammatory Signature and Enrichment in Peripheral Blood Monocyte-Related Genes
Vitor Leonardo Bassan, Rafaela de Freitas Martins Felício, Kelen Cristina Ribeiro Malmegrim, et al.
Cancer Investigation (2024) Vol. 42, Iss. 7, pp. 605-618
Closed Access
Abdominal aortic calcification in patients newly diagnosed with essential thrombocythemia
Myung-Won Lee, Jeong Suk Koh, Sora Kang, et al.
Blood Research (2023) Vol. 58, Iss. 4, pp. 173-180
Open Access | Times Cited: 1
Gut microbiota and myeloproliferative neoplams
Adeniyi Abraham Adesola, Yongfeng Chen, Mihnea‐Alexandru Găman
Journal of the Pakistan Medical Association (2023) Vol. 73, Iss. 12, pp. 2334-2335
Open Access | Times Cited: 1
Trisomy 8-positive Polycythemia Vera Complicated with Intestinal Behçet's-like Disease: A New Perspective for a Clinical Approach
Yuki Mori, Fumihiko Iwamoto, Toru Kuno, et al.
Internal Medicine (2021) Vol. 61, Iss. 11, pp. 1713-1719
Open Access | Times Cited: 2
The Development of Primary Effusion Lymphoma-Like Lymphoma in a Patient with Preexisting Essential Thrombocythemia
Yoshiki Uemura, Marina Komoto, Mitsuo Okada
Case Reports in Hematology (2021) Vol. 2021, pp. 1-6
Open Access | Times Cited: 1
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms
Jessica E. Pritchard, Juliette E. Pearce, Inge Snoeren, et al.
Cell Reports (2023) Vol. 43, Iss. 1, pp. 113608-113608
Open Access
CRP, TNF, VEGF, FGF and PNTX Blood Levels in Patients with Essential Thrombocytosis and Polistemia Vera
Cengiz Ceylan, Murat Akşit, Mehmet Can Uğur, et al.
Turkiye Klinikleri Cardiovascular Sciences (2019) Vol. 31, Iss. 3, pp. 143-147
Open Access
[The anti-proliferative and anti-inflammatory mechanisms of JAK1 inhibitor SHR0302 versus Ruxolitinib in SET2 cell line and primary cells].
Aiying Yang, Jinqin Liu, Ya’nan Cai, et al.
PubMed (2019) Vol. 40, Iss. 12, pp. 1003-1007
Closed Access
Previous Page - Page 2

Scroll to top